nodes	percent_of_prediction	percent_of_DWPC	metapath
Darunavir—CYP3A4—breast cancer	0.309	1	CbGaD
Darunavir—CYP3A4—Exemestane—breast cancer	0.0594	0.133	CbGbCtD
Darunavir—CYP3A4—Letrozole—breast cancer	0.0505	0.113	CbGbCtD
Darunavir—CYP3A4—Anastrozole—breast cancer	0.045	0.101	CbGbCtD
Darunavir—CYP3A4—Toremifene—breast cancer	0.0412	0.0921	CbGbCtD
Darunavir—CYP3A4—Fulvestrant—breast cancer	0.0383	0.0856	CbGbCtD
Darunavir—CYP3A4—Thiotepa—breast cancer	0.0341	0.0763	CbGbCtD
Darunavir—CYP3A4—Ixabepilone—breast cancer	0.0312	0.0698	CbGbCtD
Darunavir—CYP3A4—Lapatinib—breast cancer	0.03	0.0672	CbGbCtD
Darunavir—CYP3A4—Raloxifene—breast cancer	0.0228	0.0509	CbGbCtD
Darunavir—CYP3A4—Vinorelbine—breast cancer	0.0167	0.0372	CbGbCtD
Darunavir—CYP3A4—Tamoxifen—breast cancer	0.015	0.0336	CbGbCtD
Darunavir—CYP3A4—Mitoxantrone—breast cancer	0.0147	0.0328	CbGbCtD
Darunavir—CYP3A4—Paclitaxel—breast cancer	0.0117	0.0262	CbGbCtD
Darunavir—CYP3A4—Irinotecan—breast cancer	0.0115	0.0258	CbGbCtD
Darunavir—CYP3A4—Vinblastine—breast cancer	0.0103	0.023	CbGbCtD
Darunavir—CYP3A4—Docetaxel—breast cancer	0.00846	0.0189	CbGbCtD
Darunavir—CYP3A4—Doxorubicin—breast cancer	0.00631	0.0141	CbGbCtD
Darunavir—Amprenavir—ABCC1—breast cancer	0.00177	0.412	CrCbGaD
Darunavir—Fosamprenavir—CYP3A4—breast cancer	0.00113	0.262	CrCbGaD
Darunavir—Amprenavir—CYP2D6—breast cancer	0.000545	0.127	CrCbGaD
Darunavir—Amprenavir—CYP3A4—breast cancer	0.000467	0.109	CrCbGaD
Darunavir—Amprenavir—ABCB1—breast cancer	0.000389	0.0905	CrCbGaD
Darunavir—Headache—Gemcitabine—breast cancer	3.08e-05	0.000128	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Capecitabine—breast cancer	3.08e-05	0.000128	CcSEcCtD
Darunavir—Flushing—Epirubicin—breast cancer	3.07e-05	0.000128	CcSEcCtD
Darunavir—Cardiac disorder—Epirubicin—breast cancer	3.07e-05	0.000128	CcSEcCtD
Darunavir—Vomiting—Fluorouracil—breast cancer	3.07e-05	0.000128	CcSEcCtD
Darunavir—Dyspepsia—Docetaxel—breast cancer	3.07e-05	0.000128	CcSEcCtD
Darunavir—Haemorrhage—Doxorubicin—breast cancer	3.06e-05	0.000128	CcSEcCtD
Darunavir—Hepatitis—Doxorubicin—breast cancer	3.06e-05	0.000128	CcSEcCtD
Darunavir—Insomnia—Capecitabine—breast cancer	3.05e-05	0.000127	CcSEcCtD
Darunavir—Hypoaesthesia—Doxorubicin—breast cancer	3.05e-05	0.000127	CcSEcCtD
Darunavir—Rash—Fluorouracil—breast cancer	3.05e-05	0.000127	CcSEcCtD
Darunavir—Dermatitis—Fluorouracil—breast cancer	3.04e-05	0.000127	CcSEcCtD
Darunavir—Paraesthesia—Capecitabine—breast cancer	3.03e-05	0.000126	CcSEcCtD
Darunavir—Decreased appetite—Docetaxel—breast cancer	3.03e-05	0.000126	CcSEcCtD
Darunavir—Hypersensitivity—Paclitaxel—breast cancer	3.03e-05	0.000126	CcSEcCtD
Darunavir—Headache—Fluorouracil—breast cancer	3.03e-05	0.000126	CcSEcCtD
Darunavir—Urinary tract disorder—Doxorubicin—breast cancer	3.03e-05	0.000126	CcSEcCtD
Darunavir—Oedema peripheral—Doxorubicin—breast cancer	3.02e-05	0.000126	CcSEcCtD
Darunavir—Dysgeusia—Methotrexate—breast cancer	3.02e-05	0.000126	CcSEcCtD
Darunavir—Gastrointestinal disorder—Docetaxel—breast cancer	3.01e-05	0.000126	CcSEcCtD
Darunavir—Connective tissue disorder—Doxorubicin—breast cancer	3.01e-05	0.000125	CcSEcCtD
Darunavir—Dyspnoea—Capecitabine—breast cancer	3.01e-05	0.000125	CcSEcCtD
Darunavir—Fatigue—Docetaxel—breast cancer	3.01e-05	0.000125	CcSEcCtD
Darunavir—Angiopathy—Epirubicin—breast cancer	3e-05	0.000125	CcSEcCtD
Darunavir—Urethral disorder—Doxorubicin—breast cancer	3e-05	0.000125	CcSEcCtD
Darunavir—Nausea—Mitoxantrone—breast cancer	3e-05	0.000125	CcSEcCtD
Darunavir—Nausea—Irinotecan—breast cancer	3e-05	0.000125	CcSEcCtD
Darunavir—Immune system disorder—Epirubicin—breast cancer	2.99e-05	0.000125	CcSEcCtD
Darunavir—Mediastinal disorder—Epirubicin—breast cancer	2.98e-05	0.000124	CcSEcCtD
Darunavir—Constipation—Docetaxel—breast cancer	2.98e-05	0.000124	CcSEcCtD
Darunavir—Pain—Docetaxel—breast cancer	2.98e-05	0.000124	CcSEcCtD
Darunavir—Dyspepsia—Capecitabine—breast cancer	2.97e-05	0.000124	CcSEcCtD
Darunavir—Chills—Epirubicin—breast cancer	2.97e-05	0.000124	CcSEcCtD
Darunavir—Visual impairment—Doxorubicin—breast cancer	2.95e-05	0.000123	CcSEcCtD
Darunavir—Asthenia—Paclitaxel—breast cancer	2.95e-05	0.000123	CcSEcCtD
Darunavir—Decreased appetite—Capecitabine—breast cancer	2.94e-05	0.000122	CcSEcCtD
Darunavir—Alopecia—Epirubicin—breast cancer	2.93e-05	0.000122	CcSEcCtD
Darunavir—Nausea—Gemcitabine—breast cancer	2.92e-05	0.000122	CcSEcCtD
Darunavir—Gastrointestinal disorder—Capecitabine—breast cancer	2.92e-05	0.000122	CcSEcCtD
Darunavir—Fatigue—Capecitabine—breast cancer	2.91e-05	0.000121	CcSEcCtD
Darunavir—Pruritus—Paclitaxel—breast cancer	2.91e-05	0.000121	CcSEcCtD
Darunavir—Mental disorder—Epirubicin—breast cancer	2.9e-05	0.000121	CcSEcCtD
Darunavir—Erythema multiforme—Doxorubicin—breast cancer	2.9e-05	0.000121	CcSEcCtD
Darunavir—Pain—Capecitabine—breast cancer	2.89e-05	0.00012	CcSEcCtD
Darunavir—Constipation—Capecitabine—breast cancer	2.89e-05	0.00012	CcSEcCtD
Darunavir—Malnutrition—Epirubicin—breast cancer	2.88e-05	0.00012	CcSEcCtD
Darunavir—Erythema—Epirubicin—breast cancer	2.88e-05	0.00012	CcSEcCtD
Darunavir—Feeling abnormal—Docetaxel—breast cancer	2.87e-05	0.00012	CcSEcCtD
Darunavir—Nausea—Fluorouracil—breast cancer	2.87e-05	0.00012	CcSEcCtD
Darunavir—Eye disorder—Doxorubicin—breast cancer	2.86e-05	0.000119	CcSEcCtD
Darunavir—Ill-defined disorder—Methotrexate—breast cancer	2.86e-05	0.000119	CcSEcCtD
Darunavir—Gastrointestinal pain—Docetaxel—breast cancer	2.85e-05	0.000119	CcSEcCtD
Darunavir—Anaemia—Methotrexate—breast cancer	2.85e-05	0.000119	CcSEcCtD
Darunavir—Flushing—Doxorubicin—breast cancer	2.84e-05	0.000119	CcSEcCtD
Darunavir—Cardiac disorder—Doxorubicin—breast cancer	2.84e-05	0.000119	CcSEcCtD
Darunavir—Flatulence—Epirubicin—breast cancer	2.84e-05	0.000118	CcSEcCtD
Darunavir—Dysgeusia—Epirubicin—breast cancer	2.82e-05	0.000118	CcSEcCtD
Darunavir—Diarrhoea—Paclitaxel—breast cancer	2.82e-05	0.000117	CcSEcCtD
Darunavir—Feeling abnormal—Capecitabine—breast cancer	2.78e-05	0.000116	CcSEcCtD
Darunavir—Angiopathy—Doxorubicin—breast cancer	2.78e-05	0.000116	CcSEcCtD
Darunavir—Malaise—Methotrexate—breast cancer	2.78e-05	0.000116	CcSEcCtD
Darunavir—Muscle spasms—Epirubicin—breast cancer	2.77e-05	0.000116	CcSEcCtD
Darunavir—Immune system disorder—Doxorubicin—breast cancer	2.77e-05	0.000115	CcSEcCtD
Darunavir—Vertigo—Methotrexate—breast cancer	2.77e-05	0.000115	CcSEcCtD
Darunavir—Gastrointestinal pain—Capecitabine—breast cancer	2.76e-05	0.000115	CcSEcCtD
Darunavir—Mediastinal disorder—Doxorubicin—breast cancer	2.76e-05	0.000115	CcSEcCtD
Darunavir—Abdominal pain—Docetaxel—breast cancer	2.76e-05	0.000115	CcSEcCtD
Darunavir—Body temperature increased—Docetaxel—breast cancer	2.76e-05	0.000115	CcSEcCtD
Darunavir—Leukopenia—Methotrexate—breast cancer	2.76e-05	0.000115	CcSEcCtD
Darunavir—Chills—Doxorubicin—breast cancer	2.75e-05	0.000115	CcSEcCtD
Darunavir—Dizziness—Paclitaxel—breast cancer	2.72e-05	0.000113	CcSEcCtD
Darunavir—Alopecia—Doxorubicin—breast cancer	2.71e-05	0.000113	CcSEcCtD
Darunavir—Cough—Methotrexate—breast cancer	2.69e-05	0.000112	CcSEcCtD
Darunavir—Mental disorder—Doxorubicin—breast cancer	2.68e-05	0.000112	CcSEcCtD
Darunavir—Urticaria—Capecitabine—breast cancer	2.68e-05	0.000112	CcSEcCtD
Darunavir—Ill-defined disorder—Epirubicin—breast cancer	2.67e-05	0.000111	CcSEcCtD
Darunavir—Abdominal pain—Capecitabine—breast cancer	2.67e-05	0.000111	CcSEcCtD
Darunavir—Body temperature increased—Capecitabine—breast cancer	2.67e-05	0.000111	CcSEcCtD
Darunavir—Convulsion—Methotrexate—breast cancer	2.67e-05	0.000111	CcSEcCtD
Darunavir—Erythema—Doxorubicin—breast cancer	2.67e-05	0.000111	CcSEcCtD
Darunavir—Malnutrition—Doxorubicin—breast cancer	2.67e-05	0.000111	CcSEcCtD
Darunavir—Anaemia—Epirubicin—breast cancer	2.66e-05	0.000111	CcSEcCtD
Darunavir—Agitation—Epirubicin—breast cancer	2.65e-05	0.00011	CcSEcCtD
Darunavir—Flatulence—Doxorubicin—breast cancer	2.63e-05	0.00011	CcSEcCtD
Darunavir—Myalgia—Methotrexate—breast cancer	2.62e-05	0.000109	CcSEcCtD
Darunavir—Chest pain—Methotrexate—breast cancer	2.62e-05	0.000109	CcSEcCtD
Darunavir—Arthralgia—Methotrexate—breast cancer	2.62e-05	0.000109	CcSEcCtD
Darunavir—Vomiting—Paclitaxel—breast cancer	2.62e-05	0.000109	CcSEcCtD
Darunavir—Dysgeusia—Doxorubicin—breast cancer	2.61e-05	0.000109	CcSEcCtD
Darunavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	2.6e-05	0.000109	CcSEcCtD
Darunavir—Malaise—Epirubicin—breast cancer	2.6e-05	0.000108	CcSEcCtD
Darunavir—Rash—Paclitaxel—breast cancer	2.59e-05	0.000108	CcSEcCtD
Darunavir—Dermatitis—Paclitaxel—breast cancer	2.59e-05	0.000108	CcSEcCtD
Darunavir—Discomfort—Methotrexate—breast cancer	2.59e-05	0.000108	CcSEcCtD
Darunavir—Vertigo—Epirubicin—breast cancer	2.59e-05	0.000108	CcSEcCtD
Darunavir—Syncope—Epirubicin—breast cancer	2.59e-05	0.000108	CcSEcCtD
Darunavir—Leukopenia—Epirubicin—breast cancer	2.58e-05	0.000108	CcSEcCtD
Darunavir—Headache—Paclitaxel—breast cancer	2.58e-05	0.000107	CcSEcCtD
Darunavir—Hypersensitivity—Docetaxel—breast cancer	2.57e-05	0.000107	CcSEcCtD
Darunavir—Muscle spasms—Doxorubicin—breast cancer	2.56e-05	0.000107	CcSEcCtD
Darunavir—Palpitations—Epirubicin—breast cancer	2.55e-05	0.000106	CcSEcCtD
Darunavir—Confusional state—Methotrexate—breast cancer	2.54e-05	0.000106	CcSEcCtD
Darunavir—Loss of consciousness—Epirubicin—breast cancer	2.53e-05	0.000106	CcSEcCtD
Darunavir—Cough—Epirubicin—breast cancer	2.52e-05	0.000105	CcSEcCtD
Darunavir—Asthenia—Docetaxel—breast cancer	2.5e-05	0.000104	CcSEcCtD
Darunavir—Convulsion—Epirubicin—breast cancer	2.5e-05	0.000104	CcSEcCtD
Darunavir—Hypertension—Epirubicin—breast cancer	2.49e-05	0.000104	CcSEcCtD
Darunavir—Hypersensitivity—Capecitabine—breast cancer	2.49e-05	0.000104	CcSEcCtD
Darunavir—Ill-defined disorder—Doxorubicin—breast cancer	2.48e-05	0.000103	CcSEcCtD
Darunavir—Pruritus—Docetaxel—breast cancer	2.47e-05	0.000103	CcSEcCtD
Darunavir—Nervous system disorder—Methotrexate—breast cancer	2.47e-05	0.000103	CcSEcCtD
Darunavir—Anaemia—Doxorubicin—breast cancer	2.47e-05	0.000103	CcSEcCtD
Darunavir—Thrombocytopenia—Methotrexate—breast cancer	2.46e-05	0.000103	CcSEcCtD
Darunavir—Chest pain—Epirubicin—breast cancer	2.45e-05	0.000102	CcSEcCtD
Darunavir—Arthralgia—Epirubicin—breast cancer	2.45e-05	0.000102	CcSEcCtD
Darunavir—Myalgia—Epirubicin—breast cancer	2.45e-05	0.000102	CcSEcCtD
Darunavir—Agitation—Doxorubicin—breast cancer	2.45e-05	0.000102	CcSEcCtD
Darunavir—Anxiety—Epirubicin—breast cancer	2.45e-05	0.000102	CcSEcCtD
Darunavir—Nausea—Paclitaxel—breast cancer	2.44e-05	0.000102	CcSEcCtD
Darunavir—Skin disorder—Methotrexate—breast cancer	2.44e-05	0.000102	CcSEcCtD
Darunavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	2.44e-05	0.000102	CcSEcCtD
Darunavir—Hyperhidrosis—Methotrexate—breast cancer	2.43e-05	0.000101	CcSEcCtD
Darunavir—Discomfort—Epirubicin—breast cancer	2.42e-05	0.000101	CcSEcCtD
Darunavir—Asthenia—Capecitabine—breast cancer	2.42e-05	0.000101	CcSEcCtD
Darunavir—Malaise—Doxorubicin—breast cancer	2.41e-05	0.0001	CcSEcCtD
Darunavir—Dry mouth—Epirubicin—breast cancer	2.4e-05	0.0001	CcSEcCtD
Darunavir—Vertigo—Doxorubicin—breast cancer	2.4e-05	9.99e-05	CcSEcCtD
Darunavir—Anorexia—Methotrexate—breast cancer	2.4e-05	9.99e-05	CcSEcCtD
Darunavir—Syncope—Doxorubicin—breast cancer	2.39e-05	9.97e-05	CcSEcCtD
Darunavir—Pruritus—Capecitabine—breast cancer	2.39e-05	9.96e-05	CcSEcCtD
Darunavir—Leukopenia—Doxorubicin—breast cancer	2.39e-05	9.95e-05	CcSEcCtD
Darunavir—Diarrhoea—Docetaxel—breast cancer	2.39e-05	9.95e-05	CcSEcCtD
Darunavir—Confusional state—Epirubicin—breast cancer	2.37e-05	9.89e-05	CcSEcCtD
Darunavir—Palpitations—Doxorubicin—breast cancer	2.36e-05	9.82e-05	CcSEcCtD
Darunavir—Loss of consciousness—Doxorubicin—breast cancer	2.34e-05	9.77e-05	CcSEcCtD
Darunavir—Cough—Doxorubicin—breast cancer	2.33e-05	9.7e-05	CcSEcCtD
Darunavir—Shock—Epirubicin—breast cancer	2.31e-05	9.65e-05	CcSEcCtD
Darunavir—Convulsion—Doxorubicin—breast cancer	2.31e-05	9.63e-05	CcSEcCtD
Darunavir—Diarrhoea—Capecitabine—breast cancer	2.31e-05	9.63e-05	CcSEcCtD
Darunavir—Nervous system disorder—Epirubicin—breast cancer	2.31e-05	9.62e-05	CcSEcCtD
Darunavir—Dizziness—Docetaxel—breast cancer	2.31e-05	9.61e-05	CcSEcCtD
Darunavir—Thrombocytopenia—Epirubicin—breast cancer	2.3e-05	9.6e-05	CcSEcCtD
Darunavir—Hypertension—Doxorubicin—breast cancer	2.3e-05	9.6e-05	CcSEcCtD
Darunavir—Tachycardia—Epirubicin—breast cancer	2.3e-05	9.57e-05	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Methotrexate—breast cancer	2.29e-05	9.55e-05	CcSEcCtD
Darunavir—Skin disorder—Epirubicin—breast cancer	2.29e-05	9.52e-05	CcSEcCtD
Darunavir—Hyperhidrosis—Epirubicin—breast cancer	2.27e-05	9.48e-05	CcSEcCtD
Darunavir—Insomnia—Methotrexate—breast cancer	2.27e-05	9.48e-05	CcSEcCtD
Darunavir—Myalgia—Doxorubicin—breast cancer	2.27e-05	9.46e-05	CcSEcCtD
Darunavir—Arthralgia—Doxorubicin—breast cancer	2.27e-05	9.46e-05	CcSEcCtD
Darunavir—Chest pain—Doxorubicin—breast cancer	2.27e-05	9.46e-05	CcSEcCtD
Darunavir—Anxiety—Doxorubicin—breast cancer	2.26e-05	9.43e-05	CcSEcCtD
Darunavir—Paraesthesia—Methotrexate—breast cancer	2.26e-05	9.41e-05	CcSEcCtD
Darunavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	2.26e-05	9.4e-05	CcSEcCtD
Darunavir—Discomfort—Doxorubicin—breast cancer	2.24e-05	9.35e-05	CcSEcCtD
Darunavir—Anorexia—Epirubicin—breast cancer	2.24e-05	9.35e-05	CcSEcCtD
Darunavir—Dyspnoea—Methotrexate—breast cancer	2.24e-05	9.34e-05	CcSEcCtD
Darunavir—Somnolence—Methotrexate—breast cancer	2.24e-05	9.31e-05	CcSEcCtD
Darunavir—Dizziness—Capecitabine—breast cancer	2.23e-05	9.31e-05	CcSEcCtD
Darunavir—Dry mouth—Doxorubicin—breast cancer	2.22e-05	9.26e-05	CcSEcCtD
Darunavir—Vomiting—Docetaxel—breast cancer	2.22e-05	9.24e-05	CcSEcCtD
Darunavir—Dyspepsia—Methotrexate—breast cancer	2.21e-05	9.22e-05	CcSEcCtD
Darunavir—Rash—Docetaxel—breast cancer	2.2e-05	9.17e-05	CcSEcCtD
Darunavir—Dermatitis—Docetaxel—breast cancer	2.2e-05	9.16e-05	CcSEcCtD
Darunavir—Confusional state—Doxorubicin—breast cancer	2.2e-05	9.15e-05	CcSEcCtD
Darunavir—Decreased appetite—Methotrexate—breast cancer	2.19e-05	9.11e-05	CcSEcCtD
Darunavir—Headache—Docetaxel—breast cancer	2.19e-05	9.11e-05	CcSEcCtD
Darunavir—Gastrointestinal disorder—Methotrexate—breast cancer	2.17e-05	9.05e-05	CcSEcCtD
Darunavir—Fatigue—Methotrexate—breast cancer	2.17e-05	9.03e-05	CcSEcCtD
Darunavir—Pain—Methotrexate—breast cancer	2.15e-05	8.96e-05	CcSEcCtD
Darunavir—Vomiting—Capecitabine—breast cancer	2.15e-05	8.95e-05	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Epirubicin—breast cancer	2.14e-05	8.93e-05	CcSEcCtD
Darunavir—Shock—Doxorubicin—breast cancer	2.14e-05	8.93e-05	CcSEcCtD
Darunavir—Nervous system disorder—Doxorubicin—breast cancer	2.13e-05	8.9e-05	CcSEcCtD
Darunavir—Thrombocytopenia—Doxorubicin—breast cancer	2.13e-05	8.88e-05	CcSEcCtD
Darunavir—Rash—Capecitabine—breast cancer	2.13e-05	8.87e-05	CcSEcCtD
Darunavir—Insomnia—Epirubicin—breast cancer	2.13e-05	8.87e-05	CcSEcCtD
Darunavir—Dermatitis—Capecitabine—breast cancer	2.13e-05	8.87e-05	CcSEcCtD
Darunavir—Tachycardia—Doxorubicin—breast cancer	2.12e-05	8.85e-05	CcSEcCtD
Darunavir—Headache—Capecitabine—breast cancer	2.12e-05	8.82e-05	CcSEcCtD
Darunavir—Skin disorder—Doxorubicin—breast cancer	2.11e-05	8.81e-05	CcSEcCtD
Darunavir—Paraesthesia—Epirubicin—breast cancer	2.11e-05	8.8e-05	CcSEcCtD
Darunavir—Hyperhidrosis—Doxorubicin—breast cancer	2.1e-05	8.77e-05	CcSEcCtD
Darunavir—Dyspnoea—Epirubicin—breast cancer	2.1e-05	8.74e-05	CcSEcCtD
Darunavir—Somnolence—Epirubicin—breast cancer	2.09e-05	8.72e-05	CcSEcCtD
Darunavir—Anorexia—Doxorubicin—breast cancer	2.08e-05	8.65e-05	CcSEcCtD
Darunavir—Nausea—Docetaxel—breast cancer	2.07e-05	8.64e-05	CcSEcCtD
Darunavir—Feeling abnormal—Methotrexate—breast cancer	2.07e-05	8.63e-05	CcSEcCtD
Darunavir—Dyspepsia—Epirubicin—breast cancer	2.07e-05	8.63e-05	CcSEcCtD
Darunavir—Gastrointestinal pain—Methotrexate—breast cancer	2.06e-05	8.57e-05	CcSEcCtD
Darunavir—Decreased appetite—Epirubicin—breast cancer	2.05e-05	8.52e-05	CcSEcCtD
Darunavir—Gastrointestinal disorder—Epirubicin—breast cancer	2.03e-05	8.47e-05	CcSEcCtD
Darunavir—Fatigue—Epirubicin—breast cancer	2.03e-05	8.45e-05	CcSEcCtD
Darunavir—Constipation—Epirubicin—breast cancer	2.01e-05	8.39e-05	CcSEcCtD
Darunavir—Pain—Epirubicin—breast cancer	2.01e-05	8.39e-05	CcSEcCtD
Darunavir—Nausea—Capecitabine—breast cancer	2.01e-05	8.36e-05	CcSEcCtD
Darunavir—Urticaria—Methotrexate—breast cancer	2e-05	8.32e-05	CcSEcCtD
Darunavir—Abdominal pain—Methotrexate—breast cancer	1.99e-05	8.28e-05	CcSEcCtD
Darunavir—Body temperature increased—Methotrexate—breast cancer	1.99e-05	8.28e-05	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.98e-05	8.27e-05	CcSEcCtD
Darunavir—Insomnia—Doxorubicin—breast cancer	1.97e-05	8.21e-05	CcSEcCtD
Darunavir—Paraesthesia—Doxorubicin—breast cancer	1.95e-05	8.15e-05	CcSEcCtD
Darunavir—Dyspnoea—Doxorubicin—breast cancer	1.94e-05	8.09e-05	CcSEcCtD
Darunavir—Feeling abnormal—Epirubicin—breast cancer	1.94e-05	8.08e-05	CcSEcCtD
Darunavir—Somnolence—Doxorubicin—breast cancer	1.94e-05	8.07e-05	CcSEcCtD
Darunavir—Gastrointestinal pain—Epirubicin—breast cancer	1.92e-05	8.02e-05	CcSEcCtD
Darunavir—Dyspepsia—Doxorubicin—breast cancer	1.92e-05	7.99e-05	CcSEcCtD
Darunavir—Decreased appetite—Doxorubicin—breast cancer	1.89e-05	7.89e-05	CcSEcCtD
Darunavir—Gastrointestinal disorder—Doxorubicin—breast cancer	1.88e-05	7.83e-05	CcSEcCtD
Darunavir—Fatigue—Doxorubicin—breast cancer	1.88e-05	7.82e-05	CcSEcCtD
Darunavir—Urticaria—Epirubicin—breast cancer	1.87e-05	7.79e-05	CcSEcCtD
Darunavir—Constipation—Doxorubicin—breast cancer	1.86e-05	7.76e-05	CcSEcCtD
Darunavir—Pain—Doxorubicin—breast cancer	1.86e-05	7.76e-05	CcSEcCtD
Darunavir—Abdominal pain—Epirubicin—breast cancer	1.86e-05	7.75e-05	CcSEcCtD
Darunavir—Body temperature increased—Epirubicin—breast cancer	1.86e-05	7.75e-05	CcSEcCtD
Darunavir—Hypersensitivity—Methotrexate—breast cancer	1.85e-05	7.72e-05	CcSEcCtD
Darunavir—Asthenia—Methotrexate—breast cancer	1.8e-05	7.52e-05	CcSEcCtD
Darunavir—Feeling abnormal—Doxorubicin—breast cancer	1.79e-05	7.48e-05	CcSEcCtD
Darunavir—Gastrointestinal pain—Doxorubicin—breast cancer	1.78e-05	7.42e-05	CcSEcCtD
Darunavir—Pruritus—Methotrexate—breast cancer	1.78e-05	7.41e-05	CcSEcCtD
Darunavir—Hypersensitivity—Epirubicin—breast cancer	1.73e-05	7.22e-05	CcSEcCtD
Darunavir—Urticaria—Doxorubicin—breast cancer	1.73e-05	7.21e-05	CcSEcCtD
Darunavir—Body temperature increased—Doxorubicin—breast cancer	1.72e-05	7.17e-05	CcSEcCtD
Darunavir—Abdominal pain—Doxorubicin—breast cancer	1.72e-05	7.17e-05	CcSEcCtD
Darunavir—Diarrhoea—Methotrexate—breast cancer	1.72e-05	7.17e-05	CcSEcCtD
Darunavir—Asthenia—Epirubicin—breast cancer	1.69e-05	7.04e-05	CcSEcCtD
Darunavir—Pruritus—Epirubicin—breast cancer	1.66e-05	6.94e-05	CcSEcCtD
Darunavir—Dizziness—Methotrexate—breast cancer	1.66e-05	6.93e-05	CcSEcCtD
Darunavir—Diarrhoea—Epirubicin—breast cancer	1.61e-05	6.71e-05	CcSEcCtD
Darunavir—Hypersensitivity—Doxorubicin—breast cancer	1.6e-05	6.68e-05	CcSEcCtD
Darunavir—Vomiting—Methotrexate—breast cancer	1.6e-05	6.66e-05	CcSEcCtD
Darunavir—Rash—Methotrexate—breast cancer	1.59e-05	6.61e-05	CcSEcCtD
Darunavir—Dermatitis—Methotrexate—breast cancer	1.58e-05	6.6e-05	CcSEcCtD
Darunavir—Headache—Methotrexate—breast cancer	1.58e-05	6.56e-05	CcSEcCtD
Darunavir—Asthenia—Doxorubicin—breast cancer	1.56e-05	6.51e-05	CcSEcCtD
Darunavir—Dizziness—Epirubicin—breast cancer	1.56e-05	6.48e-05	CcSEcCtD
Darunavir—Pruritus—Doxorubicin—breast cancer	1.54e-05	6.42e-05	CcSEcCtD
Darunavir—Vomiting—Epirubicin—breast cancer	1.5e-05	6.23e-05	CcSEcCtD
Darunavir—Nausea—Methotrexate—breast cancer	1.49e-05	6.22e-05	CcSEcCtD
Darunavir—Diarrhoea—Doxorubicin—breast cancer	1.49e-05	6.21e-05	CcSEcCtD
Darunavir—Rash—Epirubicin—breast cancer	1.48e-05	6.18e-05	CcSEcCtD
Darunavir—Dermatitis—Epirubicin—breast cancer	1.48e-05	6.18e-05	CcSEcCtD
Darunavir—Headache—Epirubicin—breast cancer	1.47e-05	6.14e-05	CcSEcCtD
Darunavir—Dizziness—Doxorubicin—breast cancer	1.44e-05	6e-05	CcSEcCtD
Darunavir—Nausea—Epirubicin—breast cancer	1.4e-05	5.82e-05	CcSEcCtD
Darunavir—Vomiting—Doxorubicin—breast cancer	1.38e-05	5.77e-05	CcSEcCtD
Darunavir—Rash—Doxorubicin—breast cancer	1.37e-05	5.72e-05	CcSEcCtD
Darunavir—Dermatitis—Doxorubicin—breast cancer	1.37e-05	5.72e-05	CcSEcCtD
Darunavir—Headache—Doxorubicin—breast cancer	1.36e-05	5.68e-05	CcSEcCtD
Darunavir—Nausea—Doxorubicin—breast cancer	1.29e-05	5.39e-05	CcSEcCtD
